FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,019 | -79.0% | 240,575 | -52.8% | 0.00% | -66.7% |
| Q2 2023 | $2,426,662 | -41.5% | 509,803 | -29.9% | 0.00% | -50.0% |
| Q1 2023 | $4,146,676 | +48.6% | 727,487 | +163.0% | 0.01% | +50.0% |
| Q4 2022 | $2,790,531 | -100.0% | 276,564 | +3.5% | 0.00% | -60.0% |
| Q3 2022 | $5,987,459,000 | +126.4% | 267,178 | +150.3% | 0.01% | +150.0% |
| Q2 2022 | $2,645,215,000 | +56.8% | 106,748 | +145.3% | 0.00% | +100.0% |
| Q1 2022 | $1,687,464,000 | -58.9% | 43,525 | -38.0% | 0.00% | -66.7% |
| Q4 2021 | $4,105,120,000 | +116.0% | 70,161 | +118.8% | 0.01% | +100.0% |
| Q3 2021 | $1,900,670,000 | +73.4% | 32,068 | +154.0% | 0.00% | +200.0% |
| Q2 2021 | $1,095,811,000 | -2.5% | 12,626 | -7.4% | 0.00% | -50.0% |
| Q1 2021 | $1,124,453,000 | +5.0% | 13,638 | +15.8% | 0.00% | 0.0% |
| Q4 2020 | $1,070,519,000 | +59.5% | 11,773 | -29.9% | 0.00% | +100.0% |
| Q3 2020 | $671,136,000 | -82.9% | 16,791 | -85.3% | 0.00% | -85.7% |
| Q2 2020 | $3,920,569,000 | +499.4% | 114,269 | +288.0% | 0.01% | +600.0% |
| Q1 2020 | $654,129,000 | +370.5% | 29,452 | +314.6% | 0.00% | – |
| Q4 2019 | $139,025,000 | +3.3% | 7,104 | -18.1% | 0.00% | – |
| Q3 2019 | $134,630,000 | -1.5% | 8,669 | +28.8% | 0.00% | – |
| Q2 2019 | $136,680,000 | -38.3% | 6,733 | -46.6% | 0.00% | – |
| Q1 2019 | $221,417,000 | +744.7% | 12,602 | +683.2% | 0.00% | – |
| Q3 2018 | $26,211,000 | +43.7% | 1,609 | 0.0% | 0.00% | – |
| Q2 2018 | $18,246,000 | -81.0% | 1,609 | -83.6% | 0.00% | – |
| Q1 2018 | $95,843,000 | +66.5% | 9,820 | +4.2% | 0.00% | – |
| Q4 2017 | $57,575,000 | +290.7% | 9,423 | +153.2% | 0.00% | – |
| Q3 2017 | $14,735,000 | +13.8% | 3,721 | -6.9% | 0.00% | – |
| Q2 2017 | $12,950,000 | – | 3,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |